UBS Group’s MEDIROM Healthcare Technologies MRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.3K | Sell |
33,280
-65,004
| -66% | -$92.3K | ﹤0.01% | 6532 |
|
|
2025
Q1 | $36.2K | Buy |
98,284
+53,110
| +118% | +$19.5K | ﹤0.01% | 6530 |
|
|
2024
Q4 | $46.5K | Buy |
45,174
+27,137
| +150% | +$28K | ﹤0.01% | 6125 |
|
|
2024
Q3 | $54.1K | Buy |
18,037
+18,007
| +60,023% | +$54K | ﹤0.01% | 5569 |
|
|
2024
Q2 | $118 | Buy |
+30
| New | +$118 | ﹤0.01% | 7973 |
|
|
2023
Q2 | – | Sell |
-4
| Closed | -$25 | – | 8192 |
|
|
2023
Q1 | $25 | Sell |
4
-1,935
| -100% | -$12.1K | ﹤0.01% | 8300 |
|
|
2022
Q4 | $8.75K | Sell |
1,939
-173
| -8% | -$780 | ﹤0.01% | 7542 |
|
|
2022
Q3 | $13K | Buy |
2,112
+7
| +0.3% | +$43 | ﹤0.01% | 6947 |
|
|
2022
Q2 | $13K | Sell |
2,105
-9,812
| -82% | -$60.6K | ﹤0.01% | 6485 |
|
|
2022
Q1 | $88K | Sell |
11,917
-920
| -7% | -$6.79K | ﹤0.01% | 5005 |
|
|
2021
Q4 | $78K | Buy |
12,837
+12,237
| +2,040% | +$74.4K | ﹤0.01% | 5433 |
|
|
2021
Q3 | $5K | Buy |
+600
| New | +$5K | ﹤0.01% | 7394 |
|
|
2021
Q2 | – | Sell |
-1,835
| Closed | -$21K | – | 8453 |
|
|
2021
Q1 | $21K | Sell |
1,835
-566
| -24% | -$6.48K | ﹤0.01% | 6318 |
|
|
2020
Q4 | $35K | Buy |
+2,401
| New | +$35K | ﹤0.01% | 5504 |
|